Cargando…
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677141/ https://www.ncbi.nlm.nih.gov/pubmed/23354011 http://dx.doi.org/10.1038/leu.2013.26 |
| _version_ | 1782272710074695680 |
|---|---|
| author | Platzbecker, U Braulke, F Kündgen, A Götze, K Bug, G Schönefeldt, C Shirneshan, K Röllig, C Bornhäuser, M Naumann, R Neesen, J Giagounidis, A Hofmann, W-K Ehninger, G Germing, U Haase, D Wermke, M |
| author_facet | Platzbecker, U Braulke, F Kündgen, A Götze, K Bug, G Schönefeldt, C Shirneshan, K Röllig, C Bornhäuser, M Naumann, R Neesen, J Giagounidis, A Hofmann, W-K Ehninger, G Germing, U Haase, D Wermke, M |
| author_sort | Platzbecker, U |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3677141 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36771412013-06-10 Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study Platzbecker, U Braulke, F Kündgen, A Götze, K Bug, G Schönefeldt, C Shirneshan, K Röllig, C Bornhäuser, M Naumann, R Neesen, J Giagounidis, A Hofmann, W-K Ehninger, G Germing, U Haase, D Wermke, M Leukemia Letter to the Editor Nature Publishing Group 2013-06 2013-02-19 /pmc/articles/PMC3677141/ /pubmed/23354011 http://dx.doi.org/10.1038/leu.2013.26 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
| spellingShingle | Letter to the Editor Platzbecker, U Braulke, F Kündgen, A Götze, K Bug, G Schönefeldt, C Shirneshan, K Röllig, C Bornhäuser, M Naumann, R Neesen, J Giagounidis, A Hofmann, W-K Ehninger, G Germing, U Haase, D Wermke, M Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
| title | Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
| title_full | Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
| title_fullStr | Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
| title_full_unstemmed | Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
| title_short | Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study |
| title_sort | sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase i study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677141/ https://www.ncbi.nlm.nih.gov/pubmed/23354011 http://dx.doi.org/10.1038/leu.2013.26 |
| work_keys_str_mv | AT platzbeckeru sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT braulkef sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT kundgena sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT gotzek sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT bugg sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT schonefeldtc sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT shirneshank sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT rolligc sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT bornhauserm sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT naumannr sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT neesenj sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT giagounidisa sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT hofmannwk sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT ehningerg sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT germingu sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT haased sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy AT wermkem sequentialcombinationofazacitidineandlenalidomideindel5qhigherriskmyelodysplasticsyndromesoracutemyeloidleukemiaaphaseistudy |